Surgery Partners Inc. (SGRY)
Surgery Partners Statistics
Share Statistics
Surgery Partners has 127.61M shares outstanding. The number of shares has increased by 0.4% in one year.
| Shares Outstanding | 127.61M |
| Shares Change (YoY) | 0.4% |
| Shares Change (QoQ) | -0.01% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 75.52M |
| Failed to Deliver (FTD) Shares | 16.48K |
| FTD / Avg. Volume | 1.27% |
Short Selling Information
The latest short interest is 10.56M, so 8.31% of the outstanding shares have been sold short.
| Short Interest | 10.56M |
| Short % of Shares Out | 8.31% |
| Short % of Float | 14.28% |
| Short Ratio (days to cover) | 11.03 |
Valuation Ratios
The PE ratio is -15.88 and the forward PE ratio is 26.55. Surgery Partners's PEG ratio is -0.01.
| PE Ratio | -15.88 |
| Forward PE | 26.55 |
| PS Ratio | 0.86 |
| Forward PS | 0.6 |
| PB Ratio | 1.49 |
| P/FCF Ratio | 12.73 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Surgery Partners Inc. has an Enterprise Value (EV) of 6.88B.
| EV / Earnings | -40.95 |
| EV / Sales | 2.21 |
| EV / EBITDA | 13.73 |
| EV / EBIT | 19.74 |
| EV / FCF | 32.83 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.79 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.22 |
| Total Debt / Capitalization | 18.02 |
| Cash Flow / Debt | 0.76 |
| Interest Coverage | 1.73 |
Financial Efficiency
Return on equity (ROE) is -0.09% and return on capital (ROIC) is 1.13%.
| Return on Equity (ROE) | -0.09% |
| Return on Assets (ROA) | -0.02% |
| Return on Capital (ROIC) | 1.13% |
| Revenue Per Employee | $207,620 |
| Profits Per Employee | $-11,206.67 |
| Employee Count | 15,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 26.8 |
Taxes
| Income Tax | 134.6M |
| Effective Tax Rate | 0.92 |
Stock Price Statistics
The stock price has increased by -19.21% in the last 52 weeks. The beta is 2.73, so Surgery Partners's price volatility has been higher than the market average.
| Beta | 2.73 |
| 52-Week Price Change | -19.21% |
| 50-Day Moving Average | 24.12 |
| 200-Day Moving Average | 26.43 |
| Relative Strength Index (RSI) | 48.67 |
| Average Volume (20 Days) | 1.3M |
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.1M in profits. Earnings per share was -1.33.
| Revenue | 3.11B |
| Gross Profit | 745.6M |
| Operating Income | 348.8M |
| Net Income | -168.1M |
| EBITDA | 501.4M |
| EBIT | 348.8M |
| Earnings Per Share (EPS) | -1.33 |
Balance Sheet
The company has 269.5M in cash and 393.5M in debt, giving a net cash position of -124M.
| Cash & Cash Equivalents | 269.5M |
| Total Debt | 393.5M |
| Net Cash | -124M |
| Retained Earnings | -737.3M |
| Total Assets | 7.89B |
| Working Capital | 495M |
Cash Flow
In the last 12 months, operating cash flow was 300.1M and capital expenditures -90.4M, giving a free cash flow of 209.7M.
| Operating Cash Flow | 300.1M |
| Capital Expenditures | -90.4M |
| Free Cash Flow | 209.7M |
| FCF Per Share | 1.66 |
Margins
Gross margin is 23.94%, with operating and profit margins of 11.2% and -5.4%.
| Gross Margin | 23.94% |
| Operating Margin | 11.2% |
| Pretax Margin | 4.72% |
| Profit Margin | -5.4% |
| EBITDA Margin | 16.1% |
| EBIT Margin | 11.2% |
| FCF Margin | 6.73% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -5.52% |
| FCF Yield | 6.82% |
Analyst Forecast
The average price target for SGRY is $36, which is 49.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $36 |
| Price Target Difference | 49.4% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 5 |